Environmental and social justice are becoming central to discussions on sustainable development. As infrastructure projects and corporate initiatives expand worldwide, the need for responsible engagement with local communities and ecosystems has never been greater.
As organizations navigate an increasingly complex business environment, Environmental, Health, and Safety (EHS) professionals play a critical role in risk management and operational resilience.
With the Aflac WorkForces Report, we have the data to back it up: Corporate social responsibility (CSR) boosts well-being. In fact, a staggering 91% of employees who participate in their employers’ CSR initiatives say it has a positive impact.
We’re proud to once again be ranked in the top five of Americas Most Just companies in biopharma. The honor reflects our ongoing commitment to operate responsibly and empower our employees to help create a healthier world for all.
HIV infection and lung cancer have little in common from a disease perspective, but the stigma that surrounds both can negatively impact patients and their treatment. Now lessons learned from the HIV epidemic are helping people living with lung cancer and their loved ones.
We’re thrilled to announce that our online trading platform, hubbIT, was recognized as a finalist in Georgia State University - J. Mack Robinson College of Business’ 2025 Marketing Awards for Excellence in Innovation.
Georgia-Pacific’s gypsum facility in Fletcher, Okla., is experimenting with artificial intelligence to help make sure people go home the same way they came to work.
SCS Global Services, a leader in third-party sustainability certification has joined ECO Platform, a global non-profit organization focused on promoting and contributing to sustainable development of a low-carbon economy and resource efficiency in the construction sector.
In 2006, Tomas Cihlar knew all too well that despite initial successes with combination treatment, HIV was firmly holding ground around the globe and existing therapies were limited.
In recognition of Women's History Month, our Identity + Innovation spotlight features Devi SenGupta. Hear how Devi's background has shaped her approach to developing new medicines and to bringing Gilead closer to a cure for HIV.